Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 4
1967 4
1968 2
1969 1
1970 8
1971 5
1972 5
1973 9
1974 11
1975 8
1976 2
1977 4
1978 5
1980 8
1981 7
1982 4
1983 3
1984 7
1985 6
1986 4
1987 17
1988 27
1989 30
1990 23
1991 30
1992 30
1993 39
1994 26
1995 23
1996 49
1997 41
1998 37
1999 50
2000 78
2001 87
2002 95
2003 107
2004 103
2005 132
2006 112
2007 98
2008 110
2009 98
2010 85
2011 66
2012 100
2013 119
2014 131
2015 197
2016 127
2017 138
2018 112
2019 125
2020 103
2021 159
2022 112
2023 96
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

3,153 results

Results by year

Filters applied: . Clear all
Page 1
Cancer-Related Fatigue: Causes and Current Treatment Options.
Thong MSY, van Noorden CJF, Steindorf K, Arndt V. Thong MSY, et al. Curr Treat Options Oncol. 2020 Feb 5;21(2):17. doi: 10.1007/s11864-020-0707-5. Curr Treat Options Oncol. 2020. PMID: 32025928 Free PMC article. Review.
Integration of radiotherapy and immunotherapy for treatment of oligometastases.
Pitroda SP, Chmura SJ, Weichselbaum RR. Pitroda SP, et al. Lancet Oncol. 2019 Aug;20(8):e434-e442. doi: 10.1016/S1470-2045(19)30157-3. Epub 2019 Jul 29. Lancet Oncol. 2019. PMID: 31364595 Review.
Mounting evidence supports the idea that patients with numerically and spatially restricted sites of metastases, termed oligometastases, can achieve prolonged survival following metastasis-directed therapies, such as surgery or radiotherapy. Improvements in clinical and mo …
Mounting evidence supports the idea that patients with numerically and spatially restricted sites of metastases, termed oligometastases, can …
The future of personalised radiotherapy for head and neck cancer.
Caudell JJ, Torres-Roca JF, Gillies RJ, Enderling H, Kim S, Rishi A, Moros EG, Harrison LB. Caudell JJ, et al. Lancet Oncol. 2017 May;18(5):e266-e273. doi: 10.1016/S1470-2045(17)30252-8. Epub 2017 Apr 26. Lancet Oncol. 2017. PMID: 28456586 Free PMC article. Review.
Radiotherapy has long been the mainstay of treatment for patients with head and neck cancer and has traditionally involved a stage-dependent strategy whereby all patients with the same TNM stage receive the same therapy. We believe there is a substantial opportunity to imp …
Radiotherapy has long been the mainstay of treatment for patients with head and neck cancer and has traditionally involved a stage-de …
Radiotherapy resources in Brazil (RT2030): a comprehensive analysis and projections for 2030.
Rosa AA, de Sousa CFPM, Pimentel LCF, Martins HL, Moraes FY, Marta GN, Castilho MS. Rosa AA, et al. Lancet Oncol. 2023 Aug;24(8):903-912. doi: 10.1016/S1470-2045(23)00284-X. Lancet Oncol. 2023. PMID: 37541272 Review.
A pre-planned review of available databases was done to gather data on active radiation oncology centres and the distribution of radiotherapy machines (linear accelerators [LINACs]) across Brazil. We used national population and cancer incidence projections, recommended …
A pre-planned review of available databases was done to gather data on active radiation oncology centres and the distribution of radiothe …
Spinal osteosarcoma.
Katonis P, Datsis G, Karantanas A, Kampouroglou A, Lianoudakis S, Licoudis S, Papoutsopoulou E, Alpantaki K. Katonis P, et al. Clin Med Insights Oncol. 2013 Aug 18;7:199-208. doi: 10.4137/CMO.S10099. Clin Med Insights Oncol. 2013. PMID: 24179411 Free PMC article. Review.
Even though overall prognosis remains poor, en-block tumor removal combined with adjuvant radiotherapy and chemotherapy is currently the treatment of choice. This paper outlines histopathological classification, epidemiology, diagnostic procedures, and current concepts of …
Even though overall prognosis remains poor, en-block tumor removal combined with adjuvant radiotherapy and chemotherapy is currently …
Radiomics in Nasopharyngeal Carcinoma.
Duan W, Xiong B, Tian T, Zou X, He Z, Zhang L. Duan W, et al. Clin Med Insights Oncol. 2022 Feb 24;16:11795549221079186. doi: 10.1177/11795549221079186. eCollection 2022. Clin Med Insights Oncol. 2022. PMID: 35237090 Free PMC article. Review.
Nasopharyngeal carcinoma (NPC) is one of the most common head and neck malignancies, and the primary treatment methods are radiotherapy and chemotherapy. Radiotherapy alone, concurrent chemoradiotherapy, and induction chemotherapy combined with concurrent chemoradio …
Nasopharyngeal carcinoma (NPC) is one of the most common head and neck malignancies, and the primary treatment methods are radiotherapy …
Global democratisation of proton radiotherapy.
Yan S, Ngoma TA, Ngwa W, Bortfeld TR. Yan S, et al. Lancet Oncol. 2023 Jun;24(6):e245-e254. doi: 10.1016/S1470-2045(23)00184-5. Lancet Oncol. 2023. PMID: 37269856 Review.
Proton radiotherapy is an advanced treatment option compared with conventional x-ray treatment, delivering much lower doses of radiation to healthy tissues surrounding the tumour. ...These developments have led to an exponential growth in the number of hospitals using prot …
Proton radiotherapy is an advanced treatment option compared with conventional x-ray treatment, delivering much lower doses of radiat …
Nasopharyngeal carcinoma.
Al-Sarraf M, Reddy MS. Al-Sarraf M, et al. Curr Treat Options Oncol. 2002 Feb;3(1):21-32. doi: 10.1007/s11864-002-0038-8. Curr Treat Options Oncol. 2002. PMID: 12057084 Review.
Nasopharyngeal carcinoma is usually present as locally advanced (stage III or IV) disease. Before 1980, the primary treatment was radiotherapy. The 5-year survival rate of patients with stage IVM0 across the world was less than 30%. ...Concurrent single-agent cisplatin and …
Nasopharyngeal carcinoma is usually present as locally advanced (stage III or IV) disease. Before 1980, the primary treatment was radioth …
Radiotherapy of follicular lymphoma: updated role and new rules.
Yahalom J. Yahalom J. Curr Treat Options Oncol. 2014 Jun;15(2):262-8. doi: 10.1007/s11864-014-0286-4. Curr Treat Options Oncol. 2014. PMID: 24700284 Free PMC article. Review.
Unfortunately, in recent years the medical oncology community has improperly underutilized radiotherapy (RT) in the management of NHL. Replacing RT with longer chemotherapy and/or immunotherapy may not necessarily be a good alternative approach and may lead to suboptimal o …
Unfortunately, in recent years the medical oncology community has improperly underutilized radiotherapy (RT) in the management of NHL …
Brain metastases.
Ewend MG, Carey LA, Morris DE, Harvey RD, Hensing TA. Ewend MG, et al. Curr Treat Options Oncol. 2001 Dec;2(6):537-47. doi: 10.1007/s11864-001-0075-8. Curr Treat Options Oncol. 2001. PMID: 12057099 Review.
Also, we must recognize differences in each tumor's sensitivity to chemotherapy and radiotherapy and differences in their biology....
Also, we must recognize differences in each tumor's sensitivity to chemotherapy and radiotherapy and differences in their biology....
3,153 results